APRE (STOCKS)
Aprea Therapeutics, Inc. Common stock
$0.850000
-0.066800 (-7.29%)
Prev close: $0.916800
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Oren Gilad
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $9.52M
- Employees
- 8
- P/E (TTM)
- -0.46
- P/B (TTM)
- 0.60
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.32 | $-0.40 | +0.0778 | +19.56% |
|
Sep 2025 (Q3)
|
$-0.47 | $-0.35 | -0.1247 | -36.11% |
|
Jun 2025 (Q2)
|
$-0.53 | $-0.76 | +0.2299 | +30.25% |
|
Dec 2024 (Q4)
|
$-0.49 | $-0.70 | +0.2104 | +30.04% |
Financial Statements
| Revenues | $285.76K |
| Benefits Costs and Expenses | $12.89M |
| Costs And Expenses | $13.52M |
| Operating Expenses | $13.52M |
| Operating Income/Loss | -$13.23M |
| Income/Loss From Continuing Operations After Tax | -$12.60M |
| Income/Loss From Continuing Operations Before Tax | -$12.60M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$12.60M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$12.60M |
| Net Income/Loss Available To Common Stockholders, Basic | -$12.60M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.93 |
| Diluted Earnings Per Share | -$1.93 |
| Basic Average Shares | 6,538,722 |
| Diluted Average Shares | 6,538,722 |
| Assets | $15.93M |
| Current Assets | $15.56M |
| Noncurrent Assets | $372.16K |
| Fixed Assets | $59.81K |
| Other Non-current Assets | $312.35K |
| Liabilities | $3.49M |
| Current Liabilities | $2.76M |
| Accounts Payable | $713.67K |
| Wages | $770.56K |
| Other Current Liabilities | $1.28M |
| Noncurrent Liabilities | $727.36K |
| Equity | $12.44M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $12.44M |
| Liabilities And Equity | $15.93M |
| Net Cash Flow From Operating Activities | -$12.89M |
| Net Cash Flow From Operating Activities, Continuing | -$12.89M |
| Net Cash Flow From Investing Activities | $8.25M |
| Net Cash Flow From Investing Activities, Continuing | $8.25M |
| Net Cash Flow From Financing Activities | $4.64M |
| Net Cash Flow From Financing Activities, Continuing | $4.64M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$12.61M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$12.61M |
| Other Comprehensive Income/Loss | -$7.34K |